Physician profile
Stephen D Ford
NPI 1447290408
$1,580.80
in general payments reported to CMS, 2019-2025
19 companies · $389 in 2025
The $389 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2020: $62.70 · 2021: $289 · 2022: $464 · 2023: $102 · 2024: $143 · 2025: $389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $634.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $633.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $480.99 | 2022-2025 | |
| Abbott Laboratories | $237.47 | 2022-2025 | Freestyle Libre 3 |
| Abbvie INC. | $131.32 | 2022 | |
| Novo Nordisk INC | $89.60 | 2019-2025 | Ozempic, Rybelsus |
| Senseonics, Incorporated | $85.00 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $75.97 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.16 | 2021-2022 | |
| Lilly USA, LLC | $57.21 | 2021-2025 | Jardiance |
| Daiichi Sankyo INC. | $55.26 | 2021-2022 | |
| Genentech USA, INC. | $53.59 | 2020-2021 | |
| Boston Scientific Corporation | $44.38 | 2023 | Angiojet Ultra 5000a |
| Pfizer INC. | $41.67 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $39.09 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $29.00 | 2021-2022 | |
| Dexcom, INC. | $27.78 | 2021-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $27.03 | 2021 | |
| Glaxosmithkline, LLC. | $13.33 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.61 | 2020 | |
| Arbor Pharmaceuticals, INC. | $11.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Ford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.